Edward Mathers Sells 3,635 Shares of NeueHealth (NYSE:NEUE) Stock

Key Points

• Edward Mathers, a director at NeueHealth, sold 3,635 shares at an average price of $6.75, resulting in a total transaction value of $24,536.25.
• Following the sale, Mathers now owns 488,702 shares of NeueHealth, representing a 0.74% decrease in ownership.
• NeueHealth has a current market cap of $60.94 million and reported revenues of $209.08 million in the last quarter, which fell short of the consensus estimate of $249.50 million.

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) Director Edward Mathers sold 3,635 shares of the business's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $6.75, for a total transaction of $24,536.25. Following the transaction, the director owned 488,702 shares in the company, valued at approximately $3,298,738.50. This represents a 0.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

NeueHealth Price Performance

Shares of NEUE stock remained flat at $6.75 on Monday. NeueHealth, Inc. has a twelve month low of $3.79 and a twelve month high of $7.66. The stock has a 50 day simple moving average of $6.72 and a two-hundred day simple moving average of $6.72. The stock has a market cap of $60.94 million, a PE ratio of -0.42 and a beta of 0.59.

NeueHealth (NYSE:NEUE - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported ($1.68) earnings per share for the quarter, beating the consensus estimate of ($4.77) by $3.09. The business had revenue of $209.08 million during the quarter, compared to the consensus estimate of $249.50 million. Sell-side analysts anticipate that NeueHealth, Inc. will post -9.13 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings restated a "sell (e+)" rating on shares of NeueHealth in a report on Saturday, September 27th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Reduce" and an average price target of $7.00.

Hedge Funds Weigh In On NeueHealth

A hedge fund recently bought a new stake in NeueHealth stock. Skandinaviska Enskilda Banken AB publ bought a new position in shares of NeueHealth, Inc. (NYSE:NEUE - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 29,182 shares of the company's stock, valued at approximately $201,000. Skandinaviska Enskilda Banken AB publ owned approximately 0.32% of NeueHealth as of its most recent SEC filing. 63.88% of the stock is owned by institutional investors.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.